Filing Details

Accession Number:
0001104659-12-053799
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-02 17:42:32
Reporting Period:
2012-07-31
Filing Date:
2012-08-02
Accepted Time:
2012-08-02 17:42:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1386858 Hyperion Therapeutics Inc HPTX Pharmaceutical Preparations (2834) 611512713
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1343244 P L Vii-B Partners Capital Highland C/O Highland Capital Partners
One Broadway, 16Th Floor
Cambridge MA 02142
No No Yes No
1343673 Highland Capital Partners Vii-C Lp C/O Highland Capital Partners
One Broadway, 16Th Floor
Cambridge MA 02142
No No Yes No
1343678 Highland Capital Partners Vii Lp C/O Highland Capital Partners
One Broadway, 16Th Floor
Cambridge MA 02142
No No Yes No
1357840 Partnership Limited Vii Fund Entrepreneurs Highland C/O Highland Capital Partners
One Broadway, 16Th Floor
Cambridge MA 02142
No No Yes No
1554026 Highland Management Partners Vii, Llc C/O Highland Capital Partners
One Broadway, 16Th Floor
Cambridge MA 02142
No No Yes No
1554027 Partnership Limited Vii Partners Management Highland C/O Highland Capital Partners
One Broadway, 16Th Floor
Cambridge MA 02142
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-31 11,773 $0.00 11,845 No 4 C Indirect See Footnote
Common Stock Acquisiton 2012-07-31 13,346 $0.00 25,191 No 4 C Indirect See Footnote
Common Stock Acquisiton 2012-07-31 7,221 $0.00 32,412 No 4 C Indirect See Footnote
Common Stock Acquisiton 2012-07-31 3,002 $0.00 35,414 No 4 C Indirect See Footnote
Common Stock Acquisiton 2012-07-31 2,952 $0.00 38,366 No 4 C Indirect See Footnote
Common Stock Acquisiton 2012-07-31 2,084 $0.00 40,450 No 4 X Indirect See Footnote
Common Stock Disposition 2012-07-31 851 $0.00 39,599 No 4 J Indirect See Footnote
Common Stock Acquisiton 2012-07-31 33 $0.00 39,632 No 4 C Indirect See Footnote
Common Stock Acquisiton 2012-07-31 33 $0.00 39,665 No 4 C Indirect See Footnote
Common Stock Acquisiton 2012-07-31 1,926 $10.00 41,591 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 X Indirect See Footnote
No 4 J Indirect See Footnote
No 4 C Indirect See Footnote
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Convertible Promissory Note Disposition 2012-07-31 0 $0.00 81,334 $0.00
Common Stock Convertible Promissory Note Disposition 2012-07-31 0 $0.00 33,811 $0.00
Common Stock Convertible Promissory Note Disposition 2012-07-31 0 $0.00 33,253 $0.00
Common Stock Warrant to Purchase Common Stock Disposition 2012-07-31 23,475 $0.00 23,475 $0.00
Series C-2 Preferred Stock Warrant to Purchase Preferred Stock Disposition 2012-07-31 10,077 $0.00 10,077 $0.00
Series C-2 Preferred Stock Warrant to Purchase Preferred Stock Disposition 2012-07-31 10,077 $0.00 10,077 $0.00
Common Stock Series C-2 Preferred Stock Acquisiton 2012-07-31 10,077 $0.00 382 $0.00
Common Stock Series C-2 Preferred Stock Acquisiton 2012-07-31 10,077 $0.00 382 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2012-07-31 9,695 $10.00 9,695 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2012-07-31 9,695 $10.00 9,695 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2012-07-31 382 $0.00 382 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2012-07-31 382 $0.00 382 $0.00
Common Stock Series C-1 Preferred Stock Disposition 2012-07-31 11,773 $0.00 11,773 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2012-07-31 13,346 $0.00 13,346 $0.00
Common Stock Convertible Promissory Note Disposition 2012-07-31 0 $0.00 7,221 $0.00
Common Stock Convertible Promissory Note Disposition 2012-07-31 0 $0.00 3,002 $0.00
Common Stock Convertible Promissory Note Disposition 2012-07-31 0 $0.00 2,952 $0.00
Common Stock Warrant to Purchase Common Stock Disposition 2012-07-31 2,084 $0.00 2,084 $0.00
Series C-2 Preferred Stock Warrant to Purchase Preferred Stock Disposition 2012-07-31 894 $0.00 894 $0.00
Series C-2 Preferred Stock Warrant to Purchase Preferred Stock Disposition 2012-07-31 894 $0.00 894 $0.00
Common Stock Series C-2 Preferred Stock Acquisiton 2012-07-31 894 $0.00 894 $0.00
Common Stock Series C-2 Preferred Stock Acquisiton 2012-07-31 894 $0.00 894 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2012-07-31 861 $10.00 861 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2012-07-31 861 $10.00 861 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2012-07-31 33 $0.00 33 $0.00
Common Stock Series C-2 Preferred Stock Disposition 2012-07-31 33 $0.00 33 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 X Indirect
0 No 4 X Indirect
0 No 4 X Indirect
10,077 No 4 X Indirect
10,077 No 4 X Indirect
382 No 4 J Indirect
382 No 4 J Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 X Indirect
0 No 4 X Indirect
0 No 4 X Indirect
894 No 4 X Indirect
894 No 4 X Indirect
33 No 4 J Indirect
33 No 4 J Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The securities are held by Highland Capital Partners VII-C Limited Partnership ("HCP VII-C"). Highland Management Partners VII, LLC is the general partner of Highland Management Partnership VII Limited Partnership, which is the general partner of HCP VII-C. Each of Highland Management Partners VII Limited Partnership and Highland Management Partners VII, LLC disclaims beneficial ownership of all shares held by HCP VII-C except to the extent of each such entity's pecuniary interest therein.
  2. The securities are held by Highland Entrepreneurs' Fund VII Limited Partnership ("HEF VII"). Highland Management Partners VII, LLC is the general partner of Highland Management Partnership VII Limited Partnership, which is the general partner of HEF VII. Each of Highland Management Partners VII Limited Partnership and Highland Management Partners VII, LLC disclaims beneficial ownership of all shares held by HEF VII except to the extent of each such entity's pecuniary interest therein.
  3. Immediately prior to the closing of the Issuer's initial public offering of its common stock, each share of convertible preferred stock automatically converted into one share of common stock. The convertible preferred stock had no expiration date.
  4. Notes and accrued interest in the aggregate of $813,344 converted automatically immediately prior to the closing of the Issuer's initial public offering into shares of common stock at a conversion price of $10.00 per share, which is the initial public offering price per share.
  5. Notes and accrued interest in the aggregate of $338,118 converted automatically immediately prior to the closing of the Issuer's initial public offering into shares of common stock at a conversion price of $10.00 per share, which is the initial public offering price per share.
  6. Notes and accrued interest in the aggregate of $332,538 converted automatically immediately prior to the closing of the Issuer's initial public offering into shares of common stock at a conversion price of $10.00 per share, which is the initial public offering price per share.
  7. Notes and accrued interest in the aggregate of $72,219 converted automatically immediately prior to the closing of the Issuer's initial public offering into shares of common stock at a conversion price of $10.00 per share, which is the initial public offering price per share.
  8. Notes and accrued interest in the aggregate of $30,022 converted automatically immediately prior to the closing of the Issuer's initial public offering into shares of common stock at a conversion price of $10.00 per share, which is the initial public offering price per share.
  9. Notes and accrued interest in the aggregate of $29,527 converted automatically immediately prior to the closing of the Issuer's initial public offering into shares of common stock at a conversion price of $10.00 per share, which is the initial public offering price per share.
  10. Immediately prior to the closing, the warrants automatically net exercised by their terms, which allowed the holder to pay the exercise price of the warrants by forfeiting a portion of the exercised warrant shares with a value equal to the aggregate exercise price.
  11. Immediately prior to the closing, the warrants automatically net exercised by their terms into Series C-2 preferred stock, which allowed the holder to pay the exercise price of the warrants by forfeiting a portion of the exercised warrant shares with a value equal to the aggregate exercise price. The convertible stock had no expiration date.
  12. These shares reflect the net exercise of the preferred stock warrant pursuant to its terms into 382 shares of the Issuer's Series C-2 preferred stock.
  13. These shares reflect the net exercise of the common stock warrant pursuant to its terms into 1,233 shares of the Issuer's common stock.
  14. These shares reflect the net exercise of the preferred stock warrant pursuant to its terms into 33 shares of the Issuer's Series C-2 preferred stock.